Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sarcopenia.

Literature DB >> 29224698

Sarcopenia.

Nicholas Fuggle¹, Sarah Shaw², Elaine Dennison³, Cyrus Cooper⁴.

Abstract

Sarcopenia is a condition that is characterized by loss of muscle mass, muscle strength and muscle functional impairment with ageing. The definition of sarcopenia has been through various permutations; however, an enormous recent breakthrough is the inclusion of the condition in the ICD-10 classification of diseases. This chapter covers the background issues regarding definition before describing the epidemiology of the disease according to human and environmental factors. It then provides a practical guide for the assessment of sarcopenia in a clinical setting and finishes with advice on present treatment and the exciting frontiers of future therapies.

Entities: Chemical Disease Gene Species

Keywords: Ageing; Function; Muscle; Sarcopenia; Strength

Mesh：

Year: 2017 PMID： 29224698 PMCID： PMC5768235 DOI： 10.1016/j.berh.2017.11.007

Source DB: PubMed Journal: Best Pract Res Clin Rheumatol ISSN： 1521-6942 Impact factor: 4.098

121 in total

1. Predictors of skeletal muscle mass in elderly men and women.

Authors: R N Baumgartner; D L Waters; D Gallagher; J E Morley; P J Garry
Journal: Mech Ageing Dev Date: 1999-03-01 Impact factor: 5.432

Review 2. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases.

Authors: Rita Rastogi Kalyani; Mark Corriere; Luigi Ferrucci
Journal: Lancet Diabetes Endocrinol Date: 2014-03-06 Impact factor: 32.069

3. Trajectories of physical function decline and psychological functioning: the Quebec longitudinal study on nutrition and successful aging (NuAge).

Authors: Hélène Payette; N'Deye Rokhaya Gueye; Pierrette Gaudreau; José A Morais; Bryna Shatenstein; Katherine Gray-Donald
Journal: J Gerontol B Psychol Sci Soc Sci Date: 2010-12-06 Impact factor: 4.077

4. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability.

Authors: Ian Janssen; Steven B Heymsfield; Robert Ross
Journal: J Am Geriatr Soc Date: 2002-05 Impact factor: 5.562

5. The healthcare costs of sarcopenia in the United States.

Authors: Ian Janssen; Donald S Shepard; Peter T Katzmarzyk; Ronenn Roubenoff
Journal: J Am Geriatr Soc Date: 2004-01 Impact factor: 5.562

6. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study.

Authors: Bret H Goodpaster; Seok Won Park; Tamara B Harris; Steven B Kritchevsky; Michael Nevitt; Ann V Schwartz; Eleanor M Simonsick; Frances A Tylavsky; Marjolein Visser; Anne B Newman
Journal: J Gerontol A Biol Sci Med Sci Date: 2006-10 Impact factor: 6.053

Review 7. Physical activity improves strength, balance and endurance in adults aged 40-65 years: a systematic review.

Authors: Manuela L Ferreira; Catherine Sherrington; Kate Smith; Phil Carswell; Rebecca Bell; Morton Bell; Dafne P Nascimento; Leani Souza Máximo Pereira; Paul Vardon
Journal: J Physiother Date: 2012 Impact factor: 7.000

8. Diet and its relationship with grip strength in community-dwelling older men and women: the Hertfordshire cohort study.

Authors: Sian M Robinson; Karen A Jameson; Sue F Batelaan; Helen J Martin; Holly E Syddall; Elaine M Dennison; Cyrus Cooper; Avan Aihie Sayer
Journal: J Am Geriatr Soc Date: 2007-11-15 Impact factor: 5.562

Review 9. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials.

Authors: Charlotte Beaudart; Fanny Buckinx; Véronique Rabenda; Sophie Gillain; Etienne Cavalier; Justine Slomian; Jean Petermans; Jean-Yves Reginster; Olivier Bruyère
Journal: J Clin Endocrinol Metab Date: 2014-07-17 Impact factor: 5.958

10. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia.

Authors: D A Papanicolaou; S N Ather; H Zhu; Y Zhou; J Lutkiewicz; B B Scott; J Chandler
Journal: J Nutr Health Aging Date: 2013 Impact factor: 4.075

36 in total

1. The Effect of Age upon the Interrelationship of BMI and Inpatient Health Outcomes.

Authors: C Woolley; C Thompson; P Hakendorf; C Horwood
Journal: J Nutr Health Aging Date: 2019 Impact factor: 4.075

Review 2. MicroRNAs as modulators of longevity and the aging process.

Authors: Holly E Kinser; Zachary Pincus
Journal: Hum Genet Date: 2019-07-11 Impact factor: 4.132

Review 3. Quantification of skeletal muscle mass: sarcopenia as a marker of overall health in children and adults.

Authors: Leah A Gilligan; Alexander J Towbin; Jonathan R Dillman; Elanchezhian Somasundaram; Andrew T Trout
Journal: Pediatr Radiol Date: 2019-11-20

4. Age-related decrease in muscle satellite cells is accompanied with diminished expression of early growth response 3 in mice.

Authors: Yuji Ogura; Shuichi Sato; Mitsutoshi Kurosaka; Takashi Kotani; Hiroto Fujiya; Toshiya Funabashi
Journal: Mol Biol Rep Date: 2019-11-16 Impact factor: 2.316

10. Prognostic role of pre-sarcopenia and body composition with long-term outcomes in obstructive colorectal cancer: a retrospective cohort study.

Authors: Chul Seung Lee; Daeyoun David Won; Soon Nam Oh; Yoon Suk Lee; In Kyu Lee; In-Ho Kim; Moon Hyung Choi; Seong Taek Oh
Journal: World J Surg Oncol Date: 2020-08-28 Impact factor: 2.754